Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-010200
Filing Date
2024-02-05
Accepted
2024-02-02 17:55:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm244107-4_424b3.htm 424B3 178831
2 GRAPHIC lg_apreatherapeutics-4c.jpg GRAPHIC 27491
  Complete submission text file 0001104659-24-010200.txt   216914
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276702 | Film No.: 24593145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)